Results 281 to 290 of about 8,336,560 (363)

Assessment of genetically modified RF3 Canola Quality (CQ) <i>Brassica juncea</i> (application EFSA-GMO-NL-2019-158). [PDF]

open access: yesEFSA J
EFSA Panel on Genetically Modified Organisms (GMO)   +30 more
europepmc   +1 more source

Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin   +8 more
wiley   +1 more source

Safety evaluation of the food enzyme pectinesterase from the non-genetically modified <i>Aspergillus luchuensis</i> strain AP2 903-6. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +20 more
europepmc   +1 more source

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu   +7 more
wiley   +1 more source

Safety evaluation of an extension of use of the food enzyme chymotrypsin from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-RH. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +15 more
europepmc   +1 more source

Validation of a Cellular Imaging‐Based Method as a Potential Biomarker for SPG4 Hereditary Spastic Paraplegia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Hereditary Spastic Paraplegia (HSP) comprises a group of rare genetic diseases characterized by length‐dependent axonal degeneration of the corticospinal tracts and dorsal columns, whose main clinical feature is spastic gait. Pathogenic variants in the SPG4 gene cause Spastic Paraplegia Type 4 (SPG4‐HSP), the most common form of HSP.
Gaia Fattorini   +12 more
wiley   +1 more source

Safety evaluation of an extension of use of the food enzyme cellulase from the non-genetically modified <i>Aspergillus niger</i> strain 294. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +15 more
europepmc   +1 more source

Safety evaluation of the food enzyme dextransucrase from the genetically modified <i>Bacillus subtilis</i> strain DP-Eyp97. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +18 more
europepmc   +1 more source

Safety evaluation of an extension of use of the food enzyme pullulanase from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-LU. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy